Welcome to Tryp Therapeutics
Developing the next wave of Therapeutic Solutions
Tryp is pursuing Phase 2 clinical trials using its psilocybin and psilocin-based drug products for chronic pain and eating disorders.
A Precision Approach to Psychedelic Medicine
*Healthy volunteer dose ranging study in H1 2024 will support IND submissions for Phase 2a studies in patients
**The timetable is indicative only and is subject to change.